Test description
Calreticulin (CALR) exon 9 mutations are seen in a number of myeloproliferative neoplasms. Consider CALR mutations in conjunction with or following other molecular tests for these disorders.
Test information
Test name
CALR (Calreticulin)
Clinical indication
In the diagnostic workup of myeloproliferative neoplasms. This test is now only offered as part of the Myeloproliferative Neoplasm (MPN) panel of 31 genes.
Gene(s)
CALR
Method
NGS (Next Generation Sequencing)
Turn around time
3 – 4 weeks
Medicare eligibility
73398 or 73399 – criteria apply
Price
If not MBS eligible please contact 1800 822 999 for details
Test request form
Standard pathology request form
Sample type
Blood EDTA 6mL or Bone Marrow EDTA 4mL
Collection type
Blood or bone marrow
Special instructions
None